Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs
1. Novartis plans $23 billion investment in U.S. facilities. 2. Investment will create over 4,000 jobs, including 1,000 at Novartis. 3. Tariffs on pharmaceuticals are a concern but not the main reason. 4. Upcoming competition from Eli Lilly and Johnson & Johnson is significant. 5. NVS shares remained stable amid broader market changes.